Detalles de la búsqueda
1.
Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial.
Cephalalgia
; 43(4): 3331024231161745, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36950929
2.
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
Cephalalgia
; 41(3): 340-352, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33143451
3.
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
Headache
; 60(10): 2304-2319, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249580
4.
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study.
J Headache Pain
; 21(1): 20, 2020 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32093628
5.
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.
Cephalalgia
; 39(8): 931-944, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104507
6.
Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE-1, EVOLVE-2, and REGAIN Randomized, Double-Blind, Placebo-Controlled Studies.
Headache
; 59(2): 192-204, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30462830
7.
100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies.
Headache
; 58(9): 1347-1357, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341990
8.
Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.
World J Urol
; 32(5): 1127-32, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24504761
9.
Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine.
Headache
; 59(4): 627-628, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30973202
10.
Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials.
BMC Musculoskelet Disord
; 14: 137, 2013 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23590727
11.
Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).
J Med Econ
; 25(1): 1030-1038, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971655
12.
A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy.
Am J Mens Health
; 12(3): 567-574, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26819183
13.
The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel.
Am J Mens Health
; 12(3): 524-530, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26438471
14.
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.
Patient Prefer Adherence
; 12: 2413-2424, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30519007
15.
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.
J Am Acad Child Adolesc Psychiatry
; 46(2): 242-51, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17242628
16.
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
J Am Acad Child Adolesc Psychiatry
; 46(9): 1128-1137, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17712236
17.
Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.
J Child Adolesc Psychopharmacol
; 17(5): 689-700, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17979588
18.
Prospective Case-crossover Study Investigating the Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy and Phosphodiesterase Type 5 Inhibitor Exposure.
Urology
; 105: 76-84, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28336289
19.
Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study.
Expert Rev Neurother
; 15(11): 1353-66, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26488905
20.
Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
Clin Ther
; 36(4): 544-51, 2014 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24650448